Orthofix Medical Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $822.3M | $799.5M | $746.6M | $460.7M | $464.5M |
| Cost of revenue | $256.3M | $253.6M | $260.4M | $123.5M | $114.9M |
| Gross profit | $566.0M | $545.9M | $486.3M | $337.2M | $349.6M |
| Selling, general & administrative | $554.3M | $532.5M | $530.4M | $308.8M | — |
| Research and development | $65.8M | $73.6M | $80.2M | $49.1M | $49.6M |
| Operating income | -$81.4M | -$84.6M | -$139.1M | -$13.3M | -$8.3M |
| Pretax income | -$90.8M | -$123.9M | -$148.7M | -$17.7M | -$13.5M |
| Income tax expense | $1.4M | $2.1M | $2.7M | $2.0M | $24.9M |
| Net income | -$92.2M | -$126.0M | -$151.4M | -$19.7M | -$38.4M |
| Balance Sheet | |||||
| Cash and equivalents | $82.0M | $83.2M | $33.1M | $50.7M | $87.8M |
| Current assets | $416.8M | $433.3M | $420.4M | $256.0M | $269.5M |
| Total assets | $850.6M | $893.3M | $925.3M | $458.6M | $476.6M |
| Current liabilities | $170.5M | $168.6M | $165.2M | $83.6M | $105.8M |
| Total liabilities | $400.6M | $390.2M | $326.6M | $121.8M | $139.7M |
| Stockholders' equity | $450.0M | $503.1M | $598.7M | $336.9M | $336.9M |
| Cash Flow Statement | |||||
| Cash from operations | $33.3M | $25.8M | -$45.8M | -$11.5M | $18.5M |
| Depreciation and amortization | $77.3M | $60.1M | $53.1M | $29.0M | $29.6M |
| Stock-based compensation | $28.7M | $32.5M | $35.7M | $18.4M | $15.4M |
| Capital expenditure | $34.6M | $34.9M | $60.3M | $21.4M | $17.8M |
| Free cash flow | -$1.3M | -$9.1M | -$106.0M | -$32.9M | $690,000 |
| Impairments | — | — | — | — | $11.8M |
Shares outstanding 40.4M · Free float 53.6%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.